BigHat Bio
Meer Mustafa is a Senior Data Scientist in Discovery Biology at BigHat Biosciences since October 2023, with prior experience as Scientist II in Computational Biology at 23andMe from June to August 2023. From April 2019 to June 2023, Meer served as Senior Scientist in Bioinformatics at Alector, focusing on immunotherapies for neurodegenerative diseases and cancer. Responsibilities included leading computational biology efforts in immuno-neurology and immuno-oncology, target discovery, and technology development pipelines. Earlier roles included positions as Research Scientist at New York Genome Center and Graduate Researcher at The University of Texas at Dallas, where expertise in CRISPR functional screens, statistical algorithms, and high-volume data computation was applied. Meer holds educational credentials from New York University and The University of Texas at Dallas.
BigHat Bio
1 followers
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.